caspar: the addition of rucaparib to enzalutamide for the treatment of mcrpc
Published 2 years ago • 221 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
6:49
ramp: phase ib study of rucaparib & enzalutamide in mcrpc
-
5:15
rucaparib and olaparib: two new treatments approved for advanced prostate cancer | pcri
-
1:39
dr. howard scher on corticosteroids during treatment with enzalutamide in mcrpc
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
1:44
the delivery of niraparib and rucaparib as ovarian cancer treatment options
-
12:51
ascvd risk calculators & statin ( atherosclerotic cardiovascular disease )/ video 201 #mdtopics
-
32:43
prostate pressure relief
-
5:14
olaparib and keytruda for advanced prostate cancer | | learn about clinical trials
-
9:59
profound performance: olaparib vs. enzalutamide or abiraterone for hrr altered mcrpc
-
5:16
enzamet: enzalutamide for metastatic prostate cancer
-
1:52
clinical trial of enzamet shows it promising as prostate cancer treatment
-
1:23
the evolving treatment landscape of mhspc and mcrpc
-
1:25
procaid: capivasertib plus docetaxel and prednisolone chemotherapy for the treatment of mcrpc
-
3:44
updates from the cheiron study: docetaxel plus enzalutamide for mcrpc
-
3:41
olaparib plus abiraterone could be a new first-line treatment option for mcrpc | fred saad
-
1:44
talapro-2: exposure-safety of talazoparib enzalutamide in mcrpc
-
2:38
safety outcomes of darolutamide vs apalutamide and enzalutamide in nmcrpc
-
2:19
tomasz m. beer md, facp, on the efficacy of abiraterone enzalutamide in mcrpc
-
14:14
management of mcrpc in china
-
18:34
dr alok gupta | enzalutamide in treatment of mcrpc
-
10:00
results from acis trial of apalutamide abiraterone/prednisone in patients with chemo-naive mcrpc
-
8:42
enzalutamide and prostvac for recurrent disease